105 related articles for article (PubMed ID: 11022298)
1. [Effect of biotransformation on the receptor selectivity of muscarinic antagonists in vivo].
Kosmachev AB; Titkova TA; Fil'ko OA; Libman NM
Eksp Klin Farmakol; 2000; 63(4):13-6. PubMed ID: 11022298
[TBL] [Abstract][Full Text] [Related]
2. [Effect of pH on muscarinic antagonist selectivity].
Kosmachev AB; Iakhontova MB; Titkova TA; Fil'ko OA; Ramsh SM
Eksp Klin Farmakol; 2001; 64(3):29-32. PubMed ID: 11558434
[TBL] [Abstract][Full Text] [Related]
3. [The selectivity of the action of muscarinic agonists in vivo].
Kosmachev AB; Kosmacheva IM; Iankhotova MV; Kuleshov VI
Eksp Klin Farmakol; 1994; 57(2):6-8. PubMed ID: 8205054
[TBL] [Abstract][Full Text] [Related]
4. [The role of blockage of various M-cholinoreceptor subtypes in induction of tachycardia in rats].
Kosmachev AB; Lychakov AV; Saunkina IuA; Fil'ko OA; Chigareva SM
Eksp Klin Farmakol; 1997; 60(5):44-6. PubMed ID: 9483405
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activity and receptor-binding characteristics of 2 beta-(2'-phenyl-2'-cyclopentyl-2'-hydroxy-ethoxy)tropane and its optical isomers.
Gao ZG; Cui WY; Wang L; Liu CG
Arch Int Pharmacodyn Ther; 1996; 331(2):124-35. PubMed ID: 8937624
[TBL] [Abstract][Full Text] [Related]
6. [The role of the blockade of separate subtypes of muscarinic receptors in realizing the antidotal effect of m-cholinolytics in dimethyl dichlorovinyl phosphate poisoning].
Kosmachev AB; Beliaev VA; Fil'ko OA; Podosinovikova NP; Solov'eva NE; Titkova TA
Eksp Klin Farmakol; 1999; 62(4):55-8. PubMed ID: 10513339
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological properties of (2R)-N-[1-(6-aminopyridin-2-ylmethyl)piperidin-4-yl]-2-[(1R)-3,3-difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: a novel mucarinic antagonist with M(2)-sparing antagonistic activity.
Hirose H; Aoki I; Kimura T; Fujikawa T; Numazawa T; Sasaki K; Sato A; Hasegawa T; Nishikibe M; Mitsuya M; Ohtake N; Mase T; Noguchi K
J Pharmacol Exp Ther; 2001 May; 297(2):790-7. PubMed ID: 11303071
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
[TBL] [Abstract][Full Text] [Related]
9. Quantitative structure-selectivity relationship for M2 selectivity between M1 and M2 of piperidinyl piperidine derivatives as muscarinic antagonists.
Niu YY; Yang LM; Deng KM; Yao JH; Zhu L; Chen CY; Zhang M; Zhou JE; Shen TX; Chen HZ; Lu Y
Bioorg Med Chem Lett; 2007 Apr; 17(8):2260-6. PubMed ID: 17289384
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacological parameters of muscarinic cholinoreceptors in skeletal muscles].
Naumenko NV; Malomuzh AI; Khairova RA; Zefirov AL; Urazaev AKh
Ross Fiziol Zh Im I M Sechenova; 2002 May; 88(5):619-26. PubMed ID: 12136730
[TBL] [Abstract][Full Text] [Related]
11. Comparison of muscarinic receptor selectivity of solifenacin and oxybutynin in the bladder and submandibular gland of muscarinic receptor knockout mice.
Ito Y; Oyunzul L; Yoshida A; Fujino T; Noguchi Y; Yuyama H; Ohtake A; Suzuki M; Sasamata M; Matsui M; Yamada S
Eur J Pharmacol; 2009 Aug; 615(1-3):201-6. PubMed ID: 19446545
[TBL] [Abstract][Full Text] [Related]
12. [The antiparkinson activity of muscarinic antagonists depending on their selectivity for individual m-cholinoreceptor subtypes].
Kosmachev AB; Beliaev VA; Khrabrova AV; Fil'ko OA; Libman NM
Eksp Klin Farmakol; 1998; 61(5):3-5. PubMed ID: 9854621
[TBL] [Abstract][Full Text] [Related]
13. [The role of M-cholinoreceptor subtypes in heart rhythm disturbances of various etiology].
Kosmachev AB; Fil'ko OA; Petrov VV
Eksp Klin Farmakol; 2002; 65(1):34-6. PubMed ID: 12025782
[TBL] [Abstract][Full Text] [Related]
14. Disparate cholinergic currents in rat principal trigeminal sensory nucleus neurons mediated by M1 and M2 receptors: a possible mechanism for selective gating of afferent sensory neurotransmission.
Kohlmeier KA; Soja PJ; Kristensen MP
Eur J Neurosci; 2006 Jun; 23(12):3245-58. PubMed ID: 16820015
[TBL] [Abstract][Full Text] [Related]
15. Lithocholylcholine, a bile acid/acetylcholine hybrid, is a muscarinic receptor antagonist.
Cheng K; Khurana S; Chen Y; Kennedy RH; Zimniak P; Raufman JP
J Pharmacol Exp Ther; 2002 Oct; 303(1):29-35. PubMed ID: 12235229
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands.
Del Giudice MR; Mustazza C; Borioni A; Gatta F; Tayebati K; Amenta F; Tucci P; Pieretti S
Arch Pharm (Weinheim); 2003 Jun; 336(3):143-54. PubMed ID: 12822179
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation by carbachol of four separate excitatory afferent systems to the rat subiculum in vitro.
Kunitake A; Kunitake T; Stewart M
Hippocampus; 2004; 14(8):986-99. PubMed ID: 15390173
[TBL] [Abstract][Full Text] [Related]
18. [Dynamics of vagus nerve chronotropic effect during blockage of various M-cholinoreceptors].
Osadchiĭ OE; Pokrovskiĭ VM
Biull Eksp Biol Med; 1999 Mar; 127(3):252-5. PubMed ID: 10225091
[No Abstract] [Full Text] [Related]
19. Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor.
Yang YR; Chang KC; Chen CL; Chiu TH
Chin J Physiol; 2000 Mar; 43(1):23-8. PubMed ID: 10857465
[TBL] [Abstract][Full Text] [Related]
20. The preparation and human muscarinic receptor profiling of oxybutynin and N-desethyloxybutynin enantiomers.
Reitz AB; Gupta SK; Huang Y; Parker MH; Ryan RR
Med Chem; 2007 Nov; 3(6):543-5. PubMed ID: 18045203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
